Brief: Vyant Bio Reports Second Quarter And First Half 2022 Results
22/08/2022 21:38
Aug 22 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO REPORTS SECOND QUARTER AND FIRST HALF 2022
RESULTS AND
PROVIDES STRATEGIC AND BUSINESS HIGHLIGHTS
* VYANT BIO INC - EXPECTS CASH RUNWAY FOR APPROXIMATELY 18
MONTHS
* VYANT BIO INC QTRLY LOSS PER SHARE $0.20
Source text for Eikon: ID:nGNX6RCWW1
Further company coverage: VYNT.O
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration